Compare MRM & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRM | CPIX |
|---|---|---|
| Founded | 2000 | 1999 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.8M | 34.1M |
| IPO Year | 2020 | 2009 |
| Metric | MRM | CPIX |
|---|---|---|
| Price | $2.10 | $3.57 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 88.8K | ★ 92.6K |
| Earning Date | 05-22-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $55,915,220.00 | $41,278,349.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $51.31 | ★ N/A |
| Revenue Growth | ★ 12.79 | 12.21 |
| 52 Week Low | $0.34 | $1.85 |
| 52 Week High | $4.45 | $7.25 |
| Indicator | MRM | CPIX |
|---|---|---|
| Relative Strength Index (RSI) | 48.89 | 76.73 |
| Support Level | $2.05 | $2.42 |
| Resistance Level | $2.33 | $2.73 |
| Average True Range (ATR) | 0.09 | 0.31 |
| MACD | 0.01 | 0.16 |
| Stochastic Oscillator | 36.11 | 91.38 |
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.